COMMUNIQUÉS West-GlobeNewswire

Reata Announces Receipt of $30 Million Milestone Payment From Kyowa Hakko Kirin
31/08/2018
IRVING, Texas, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that it has received a $30 million milestone payment from its [...]
MacroGenics Announces Participation in Three Upcoming Investor Conferences
31/08/2018
Rockville, MD, Aug. 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Merus participera à la 13ème Conférence annuelle sur les biotechnologies de Citi
30/08/2018
UTRECHT, Pays-Bas, 30 août 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), une société d'immuno-oncologie au stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics®), a [...]
Dentsply Sirona to Present at the Baird 2018 Global Healthcare Conference on September 5th
30/08/2018
YORK, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq:XRAY), The Dental Solutions Company, today announced it will participate in the Baird 2018 Global Healthcare Conference on [...]
Trevena to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
CHESTERBROOK, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today, announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, [...]
Marinus Pharmaceuticals to Present at the Baird Healthcare Conference
30/08/2018
RADNOR, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
The Cooper Companies Announces Third Quarter 2018 Results
30/08/2018
PLEASANTON, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced financial results for the fiscal third quarter ended July 31, 2018. Revenue increased 19% year-over-year to $ [...]
Crinetics Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
30/08/2018
SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
HTG Molecular to Present a Corporate Overview at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
TUCSON, Ariz., Aug. 30, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ [...]
AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 10, 2018
30/08/2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Medigus Ltd Announces Second Quarter 2018 Financial Results
30/08/2018
OMER, Israel, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization [...]
Mersana Therapeutics to Present at Upcoming Investor Conferences
30/08/2018
CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Sen-Jam Pharmaceutical Reports the Positive Effect of Payer Options and Expanded Coverage for Individuals with Opioid Use Disorder
30/08/2018
HUNTINGTON, N.Y., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Opioid Epidemic is an incredibly complex and multifaceted problem facing America. We wanted to investigate the developments in medications, funding, and therapy [...]
Exonics Announces Publication of Research Demonstrating Gene Repair Technology Restored Dystrophin Expression in Canine Model of Duchenne Muscular Dystrophy
30/08/2018
Systemic delivery of SingleCut CRISPR gene editing components restored dystrophin expression to up to 92 percent of normal expression in heart muscle in canines First study of Exonics’ SingleCut technology in large [...]
Trauma-informed therapist and agency executive director Joann Schladale to receive national honor
30/08/2018
Harrisburg, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The National Sexual Violence Resource Center (NSVRC) and the Association for the Treatment of Sexual Abusers (ATSA) are pleased to honor Joann Schladale with the 2018 [...]
Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
30/08/2018
Multiple steps advance large-scale cannabis cultivation and position Emerald for industry-leading value-added manufacturing VICTORIA, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc [...]
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C
30/08/2018
ALACHUA, Fla., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]
Ogilvy CommonHealth Worldwide’s payer community flourishes with three executive level promotions
30/08/2018
PARSIPPANY, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW) ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP) ( www.wpp.com ), announced today the promotions of [...]
Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
30/08/2018
CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]

Pages